Atjaunināt sīkdatņu piekrišanu

Pathophysiology: Concepts of Human Disease [Mīkstie vāki]

  • Formāts: Paperback / softback, 1408 pages, height x width x depth: 100x100x100 mm, weight: 100 g
  • Izdošanas datums: 21-Feb-2018
  • Izdevniecība: Pearson
  • ISBN-10: 0133414787
  • ISBN-13: 9780133414783
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 143,14 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 1408 pages, height x width x depth: 100x100x100 mm, weight: 100 g
  • Izdošanas datums: 21-Feb-2018
  • Izdevniecība: Pearson
  • ISBN-10: 0133414787
  • ISBN-13: 9780133414783
Citas grāmatas par šo tēmu:

For courses in pathophysiology.

A human approach to pathophysiology, with an eye on promoting health
Pathophysiology: Concepts of Human Disease focuses on the human aspect of pathophysiology, acknowledging that diseases, disorders, and syndromes occur not in a vacuum, but in people – across the lifespan. Drawing on the health stories of real individuals, the authors provide the latest information in pathophysiology that is relevant to clinical practice, while empowering students with competencies that endure throughout a nursing career. Throughout the text, the approach to pathophysiology reflects a shift of focus in healthcare from understanding diseases in their later stages to understanding risk factors and the interventions that can maintain good health and slow progression of disease in humans.

Also available with MyLab Nursing
MyLab™ is the teaching and learning platform that empowers you to reach every student. By combining trusted author content with digital tools and a flexible platform, MyLab personalizes the learning experience and improves results for each student. MyLab Nursing helps students master key concepts, prepare for success on the NCLEX-RN® exam, and develop clinical reasoning skills.

Note: You are purchasing a standalone product; MyLab Nursing does not come packaged with this content. Students, if interested in purchasing this title with MyLab Nursing, ask your instructor to confirm the correct package ISBN and Course ID. Instructors, contact your Pearson representative for more information.

If you would like to purchase both the physical text and MyLab Nursing, search for:

013487434X / 978013487434 0 Pathophysiology: Concepts of Human Disease Plus MyNursingLab -- Access Card Package, 1/e

Package consists of:

  • 0133414787 / 9780133414783 Pathophysiology: Concepts of Human Disease, 1/e
  • 0134746783 / 9780134746784 MyNursingLab with Pearson eText 2.0 - Access Card - for Pathophysiology, 1/e
Unit I: Foundations of Pathophysiology 2(96)
Chapter 1 Introduction to the Basics of Pathophysiology
4(18)
1.1 The Language of Pathophysiology
5(3)
1.2 Overview of Health and Illness
8(2)
1.3 The Structure of Pathophysiology: Concepts of Human Disease
10(4)
1.4 Leading Indicators of Morbidity and Mortality
14(3)
1.5 The Importance of Evidence-based Practice
17(1)
Chapter Summary
17(5)
Chapter 2 Genetics, Genomics, and Epigenomics
22(25)
2.1
Chapter Overview and Case Studies
23(2)
2.2 Molecular Basis of Gene Expression
25(2)
2.3 The Human Genome, Genomics, and Epigenomics
27(1)
2.4 Gene Replication, Transcription, and Translation
28(5)
2.5 Mutations
33(1)
2.6 Categories of Genetic Disorders
34(4)
2.7 Phenotypic Variations in Human Disease
38(1)
2.8 Genes and Neoplasia/Malignancies
38(1)
2.9 Genetic-and Genomic-based Diagnostic Tests
39(1)
2.10 Linking Pathophysiology to Treatment: Genetic-and Genomic-based Therapies
40(1)
2.11 Advances in Human Genomics
41(1)
Chapter Summary
42(5)
Chapter 3 Environmental Health Influences on Disease and Injury
47(30)
3.1
Chapter Overview and Case Studies
48(3)
3.2 Environmental Hazard Classification
51(2)
3.3 Key Concepts of Environmental Health from Related Sciences
53(11)
3.4 Environmental Epidemiology
64(2)
3.5 Pathophysiologic Mechanisms
66(1)
3.6 Hazards and Health Effects of Environmental Agents
67(5)
Chapter Summary
72(5)
Chapter 4 Stress and Adaptation
77(21)
4.1
Chapter Overview and Case Studies
78(1)
4.2 Conceptualizations of Stress
79(2)
4.3 The Body in Balance
81(1)
4.4 The Body Responding to Stress
82(3)
4.5 The Effects of Stress on Health
85(3)
4.6 Stress and Mental Health
88(1)
4.7 Stress and Physical Health
89(4)
Chapter Summary
93(5)
Unit II: Risks Underlying the Leading Causes of Morbidity and Mortality 98(70)
Chapter 5 Health Risks of Obesity and Physical Inactivity
100(21)
5.1
Chapter Overview and Case Studies
101(2)
5.2 Etiology and Pathophysiology of Obesity
103(6)
5.3 Health Risks of Obesity
109(5)
5.4 Health Risks of Physical Inactivity
114(2)
Chapter Summary
116(5)
Chapter 6 Risks Related to Substance Use Disorders
121(24)
6.1
Chapter Overview and Case Studies
122(1)
6.2 Anatomy and Neurobiology of the Brain
123(3)
6.3 Alcohol Use Disorder
126(5)
6.4 Tobacco Use Disorder
131(3)
6.5 Cannabis Use Disorder
134(1)
6.6 Stimulant Use Disorders
135(3)
6.7 Hallucinogen Use Disorder
138(1)
6.8 Opioid Use Disorder
139(1)
Chapter Summary
140(5)
Chapter 7 Risks Related to Sleep Alterations
145(23)
7.1
Chapter Overview and Case Studies
146(1)
7.2 Normal Sleep
147(3)
7.3 Measurement of Sleep
150(2)
7.4 Sleep Deprivation
152(1)
7.5 Insomnia
153(2)
7.6 Sleep-Disordered Breathing
155(5)
7.7 Narcolepsy
160(1)
7.8 Restless Legs Syndrome
161(1)
7.9 Parasomnias
162(2)
Chapter Summary
164(4)
Unit III: Fluid, Electrolyte, and Acid-Base Imbalances 168(68)
Chapter 8 Fluid and Electrolyte Imbalances
170(27)
8.1
Chapter Overview and Case Studies
171(1)
8.2 Composition and Distribution of Body Fluids
172(6)
8.3 Water and Sodium Imbalances
178(7)
8.4 Chloride Imbalances
185(1)
8.5 Potassium Imbalances
186(2)
8.6 Calcium Imbalances
188(2)
8.7 Phosphorus Imbalances
190(1)
8.8 Magnesium Imbalances
191(2)
Chapter Summary
193(4)
Chapter 9 Acid-Base Imbalances
197(39)
9.1
Chapter Overview and Case Studies
198(2)
9.2 Characteristics of Acids and Bases and Their Daily Production in the Body
200(1)
9.3 Measures of Hydrogen Ion Concentration
200(1)
9.4 Regulation of Acid-Base Balance
201(7)
9.5 Types and Effects of Acid-Base Imbalances
208(4)
9.6 Laboratory Tests Used in Assessment of Acid-Base Status
212(4)
9.7 Respiratory Acidosis
216(2)
9.8 Respiratory Alkalosis
218(3)
9.9 Metabolic Acidosis
221(3)
9.10 Metabolic Alkalosis
224(3)
9.11 Mixed Acid-Base Imbalances
227(1)
9.12 Stepwise Analysis of Acid-Base Imbalances
228(1)
Chapter Summary
229(7)
Unit IV: Cell Injury, Inflammation, and Alterations of Cell Growth and Regulation 236(88)
Chapter 10 Mechanisms of Cell Injury and Aging
238(33)
10.1
Chapter Overview and Case Studies
239(1)
10.2 The Cell as the Basic Unit of Disease
240(5)
10.3 Common Causes of Cell Injury
245(4)
10.4 Environmental Factors That Cause Cell Injury
249(7)
10.5 Impact of Injury on Cell Types Present in Many Organs
256(1)
10.6 Cellular Responses to Injury
257(5)
10.7 Cell Death
262(2)
10.8 Aging of the Individual as a Result of Cellular Aging
264(2)
Chapter Summary
266(5)
Chapter 11 Inflammation
271(23)
11.1
Chapter Overview and Case Studies
272(2)
11.2 Functions of the Inflammatory Response in Health and Disease
274(2)
11.3 Acute Inflammatory Response
276(5)
11.4 Regulation and Termination of Acute Inflammation
281(1)
11.5 Morphologic Types and Outcomes of Acute Inflammation
282(1)
11.6 Chronic Inflammation
283(1)
11.7 Systemic Manifestations of Inflammation
284(1)
11.8 Impaired and Excessive Inflammation
285(1)
11.9 Overview of Disorders Associated with Chronic Inflammation
286(1)
11.10 Linking Pathophysiology to the Diagnosis and Treatment of Inflammation
287(2)
Chapter Summary
289(5)
Chapter 12 Neoplasia
294(30)
12.1
Chapter Overview and Case Studies
295(2)
12.2 Cell Cycle and Cellular Differentiation
297(2)
12.3 Molecular Basis of Cancer
299(4)
12.4 Carcinogenesis
303(2)
12.5 Cancer Invasion and Metastasis
305(2)
12.6 Epidemiology of Cancer
307(4)
12.7 Clinical Manifestations of Cancer
311(2)
12.8 Linking Pathophysiology to Diagnosis and Treatment
313(5)
Chapter Summary
318(6)
Unit V: Infection and Disorders of Immunity 324(98)
Chapter 13 Mechanisms of Infection and Host Protection
326(37)
13.1
Chapter Overview and Case Studies
327(2)
13.2 The Host-Microbe Relationship
329(2)
13.3 From Pathogen to Infectious Disease
331(5)
13.4 Microbial Agents of Infectious Disease
336(13)
13.5 The Innate and Adaptive Immune Response to Infectious Micro-Organisms
349(3)
13.6 Resistance to Infectious Disease
352(1)
13.7 Resistance to Different Microbial Pathogens as Mediated by Different Host Protective Mechanisms
353(1)
13.8 Immune Deficient/Susceptible Host
354(1)
13.9 Protection from Infectious Disease by Vaccination
355(2)
Chapter Summary
357(6)
Chapter 14 Hypersensitivity and Autoimmune Disorders
363(18)
14.1
Chapter Overview and Case Studies
364(3)
14.2 Hypersensitivity Disorders
367(7)
14.3 Autoimmune Disease
374(4)
Chapter Summary
378(3)
Chapter 15 Immunodeficiency Disorders
381(19)
15.1
Chapter Overview and Case Studies
382(1)
15.2 HIV and AIDS
383(8)
15.3 Common Conditions Associated with HIV/AIDS
391(2)
15.4 Primary Immunodeficiencies
393(2)
Chapter Summary
395(5)
Chapter 16 Disorders of White Blood Cells
400(22)
16.1
Chapter Overview and Case Studies
401(2)
16.2 Acute Myelogenous Leukemia
403(3)
16.3 Acute Lymphocytic Leukemia
406(2)
16.4 Chronic Myelogenous Leukemia
408(1)
16.5 Chronic Lymphocytic Leukemia
409(2)
16.6 Non-Hodgkin Lymphoma
411(3)
16.7 Hodgkin Lymphoma
414(1)
16.8 Multiple Myeloma
415(1)
Chapter Summary
416(6)
Unit VI: Disorders of Oxygenation 422(110)
Chapter 17 Restrictive Lung Disorders
424(16)
17.1
Chapter Overview and Case Studies
425(2)
17.2 Restrictive Lung Disorders of Pulmonary Expansion
427(7)
17.3 Restrictive Lung Disorders of Pulmonary Compliance
434(2)
Chapter Summary
436(4)
Chapter 18 Obstructive Lung Disorders
440(25)
18.1
Chapter Overview and Case Studies
441(1)
18.2 Alterations in Respiratory Structure and Function
442(3)
18.3 Asthma
445(5)
18.4 Chronic Obstructive Pulmonary Disease
450(7)
18.5 Cystic Fibrosis
457(2)
18.6 Bronchiectasis
459(1)
Chapter Summary
460(5)
Chapter 19 Neoplastic, Infectious, and Pulmonary Vascular Respiratory Disorders
465(29)
19.1
Chapter Overview and Case Studies
466(1)
19.2 Malignant Lung Tumors
467(4)
19.3 Benign Lung Lesions
471(5)
19.4 Infectious Diseases of the Upper Respiratory Tract
476(2)
19.5 Infectious Diseases of the Lower Respiratory Tract
478(8)
19.6 Pulmonary Vascular Disorders
486(3)
Chapter Summary
489(5)
Chapter 20 Respiratory Failure
494(19)
20.1
Chapter Overview and Case Studies
495(1)
20.2 Respiratory Failure: Type I and Type II
496(5)
20.3 Disorders Causing Respiratory Failure
501(8)
Chapter Summary
509(4)
Chapter 21 Disorders of Oxygen Transport
513(19)
21.1
Chapter Overview and Case Studies
514(1)
21.2 Characteristics of Anemia
515(4)
21.3 Nutritional Deficiency Anemias
519(3)
21.4 Hemolytic Anemias
522(5)
21.5 Anemia of Chronic Disease
527(1)
21.6 Polycythemia Vera
528(1)
Chapter Summary
529(3)
Unit VII: Disorders of Perfusion 532(168)
Chapter 22 Alterations of Hemostasis
534(18)
22.1
Chapter Overview and Case Studies
535(3)
22.2 Review of Hemostatic Mechanisms
538(1)
22.3 Primary Disorders of Hemostasis
539(6)
22.4 Secondary Disorders of Hemostasis
545(1)
22.5 Issues of Hypercoagulopathy
546(2)
Chapter Summary
548(4)
Chapter 23 Vascular Disorders
552(20)
23.1
Chapter Overview and Case Studies
553(2)
23.2 Peripheral Arterial Disease
555(4)
23.3 Chronic Venous Disease
559(3)
23.4 Hypertension
562(6)
Chapter Summary
568(4)
Chapter 24 Coronary Circulation Disorders
572(40)
24.1
Chapter Overview and Case Studies
573(2)
24.2 Epidemiology and Risk Factors Related to Coronary Artery Disease
575(1)
24.3 Pathophysiology, Diagnosis, and Treatment of Coronary Artery Disease
576(5)
24.4 Myocardial Ischemia and Infarction
581(7)
24.5 Specific Acute Coronary Syndromes
588(6)
24.6 Complications of Acute Coronary Syndromes
594(9)
24.7 Valvular Disorders
603(3)
Chapter Summary
606(6)
Chapter 25 Cardiac Structural Disorders
612(25)
25.1
Chapter Overview and Case Studies
613(1)
25.2 Structure of the Pediatric Cardiovascular System
614(1)
25.3 Prenatal and Postnatal Hemodynamics
615(2)
25.4 Genetics and Genomics of Critical Congenital Heart Defects
617(2)
25.5 Congenital Heart Defects
619(9)
25.6 Linking Pathophysiology to Diagnosis and Treatment of Critical Congenital Heart Defects
628(1)
25.7 Linking Pathophysiology to Diagnosis and Treatment of Adult Congenital Heart Disorders
629(2)
25.8 Noncongenital Structural Heart Defects
631(1)
25.9 Linking Pathophysiology to Diagnosis and Treatment of Noncongenital Structural Heart Defects
632(1)
Chapter Summary
633(4)
Chapter 26 Heart Failure
637(23)
26.1
Chapter Overview and Case Studies
638(1)
26.2 Classification and Staging of Heart Failure
639(3)
26.3 Systolic Heart Failure (Heart Failure with Reduced Ejection Fraction)
642(9)
26.4 Diastolic Heart Failure (Heart Failure with Preserved Ejection Fraction)
651(1)
26.5 Left-Sided Heart Failure
652(1)
26.6 Right-Sided Heart Failure
653(2)
26.7 High-Output Heart Failure
655(1)
Chapter Summary
656(4)
Chapter 27 Disorders of Circulation Within the CNS
660(20)
27.1
Chapter Overview and Case Studies
661(1)
27.2 Vascular Supply of the Central Nervous System
662(2)
27.3 Production and Circulation of Cerebrospinal Fluid
664(1)
27.4 Blood-Brain Barrier
665(1)
27.5 Cerebral Autoregulation
666(3)
27.6 Ischemia and Hypoxia of the Central Nervous System
669(1)
27.7 Transient Ischemic Attack
670(1)
27.8 Ischemic and Hemorrhagic Stroke
671(4)
27.9 Subdural and Spinal Cord Hemorrhage
675(1)
Chapter Summary
676(4)
Chapter 28 Shock and Multiple Organ Dysfunction Syndrome
680(20)
28.1
Chapter Overview and Case Studies
681(1)
28.2 Pathophysiology of Shock
682(2)
28.3 Hypovolemic Shock
684(4)
28.4 Cardiogenic Shock
688(2)
28.5 Distributive Shock
690(5)
28.6 Obstructive Shock
695(1)
28.7 Multiple Organ Dysfunction Syndrome
696(1)
Chapter Summary
696(4)
Unit VIII: Disorders of Mood and Cognition 700(48)
Chapter 29 Emotional Regulation and Mood
702(28)
29.1
Chapter Overview and Case Studies
703(1)
29.2 Anxiety
704(9)
29.3 Depression
713(9)
29.4 Bipolar Disorders
722(2)
Chapter Summary
724(6)
Chapter 30 Neurocognitive and Neurodevelopmental Disorders
730(18)
30.1
Chapter Overview and Case Studies
731(2)
30.2 Pathophysiology of Neurocognitive and Neurodevelopmental Disorders
733(2)
30.3 Schizophrenia
735(2)
30.4 Neurocognitive Disorders
737(3)
30.5 Genetic Neurodevelopmental Disorders
740(3)
Chapter Summary
743(5)
Unit IX: Disorders of Sensory Perception and Thermoregulation 748(92)
Chapter 31 Disorders of Hearing, Balance, and Vision
750(28)
31.1
Chapter Overview and Case Studies
751(2)
31.2 Basic Anatomy and Physiology of Hearing and Balance
753(2)
31.3 Conductive Hearing Loss Disorders
755(4)
31.4 Sensorineural Hearing Loss Disorders
759(6)
31.5 Basic Anatomy and Physiology of Vision
765(2)
31.6 External Eye Disorders
767(1)
31.7 Vision Disorders
768(4)
31.8 Nystagmus
772(1)
Chapter Summary
773(5)
Chapter 32 Pain, Neuropathy, and Headache
778(37)
32.1
Chapter Overview and Case Studies
779(1)
32.2 Neuroanatomy of Pain
780(7)
32.3 Assessment of Pain
787(3)
32.4 Acute Pain
790(2)
32.5 Chronic Pain
792(1)
32.6 Neuropathic Pain
793(6)
32.7 Headache
799(4)
32.8 Other Pain Syndromes
803(2)
32.9 Pain Assessment and Management in Nonverbal or Cognitively Impaired Patients
805(2)
Chapter Summary
807(8)
Chapter 33 Disorders of Thermoregulation
815(25)
33.1
Chapter Overview and Case Studies
816(2)
33.2 Body Temperature Regulation
818(1)
33.3 Thermoregulatory Processes and Control Mechanisms
818(4)
33.4 Hypothermia
822(7)
33.5 Fever
829(3)
33.6 Hyperthermia
832(2)
Chapter Summary
834(6)
Unit X: Disorders of Mobility 840(62)
Chapter 34 Disorders Affecting Motor Function
842(21)
34.1
Chapter Overview and Case Studies
843(1)
34.2 Parkinson Disease
844(4)
34.3 Multiple Sclerosis
848(5)
34.4 Amyotrophic Lateral Sclerosis
853(1)
34.5 Huntington Disease
854(2)
34.6 Seizure Disorders
856(3)
Chapter Summary
859(4)
Chapter 35 Acute Musculoskeletal Disorders
863(20)
35.1
Chapter Overview and Case Studies
864(1)
35.2 Fractures
864(7)
35.3 Dislocations and Subluxations
871(1)
35.4 Nerve Entrapment
871(1)
35.5 Bursitis
872(1)
35.6 Strains and Sprains
873(1)
35.7 Knee Injuries
873(2)
35.8 Shoulder Injuries
875(1)
35.9 Bone Infections and Tumors
876(3)
Chapter Summary
879(4)
Chapter 36 Chronic Musculoskeletal Disorders
883(19)
36.1
Chapter Overview and Case Studies
884(1)
36.2 Lower Back Pain
885(6)
36.3 Rheumatic and Arthritic Disorders
891(6)
36.4 Metabolic Bone Disease
897(2)
Chapter Summary
899(3)
Unit XI: Disorders of Endocrine Regulation 902(50)
Chapter 37 Diabetes Mellitus and Its Complications
904(29)
37.1
Chapter Overview and Case Studies
905(2)
37.2 Classification of Diabetes Mellitus and Prediabetes
907(1)
37.3 Maintenance of Normal Blood Glucose Levels
908(4)
37.4 Type 1 Diabetes Mellitus
912(2)
37.5 Type 2 Diabetes Mellitus
914(2)
37.6 Clinical Manifestations of and Diagnostic Criteria for Diabetes Mellitus
916(2)
37.7 Acute Complications of Diabetes Mellitus
918(6)
37.8 Chronic Complications of Diabetes Mellitus
924(5)
Chapter Summary
929(4)
Chapter 38 Thyroid, Parathyroid, and Adrenal Disorders
933(19)
38.1
Chapter Overview and Case Studies
934(1)
38.2 Mechanisms of Hormonal Alterations in Thyroid and Adrenal Disease
935(1)
38.3 Disorders of the Thyroid
936(5)
38.4 Disorders of the Parathyroid
941(2)
38.5 Disorders of Adrenocortical Function
943(6)
Chapter Summary
949(3)
Unit XII: Altered Tissue Integrity 952(88)
Chapter 39 Tissue and Wound Healing
954(28)
39.1
Chapter Overview and Case Studies
955(1)
39.2 The Structure of the Skin
956(5)
39.3 Cutaneous Wound Healing
961(8)
39.4 Factors Impeding Wound Healing
969(3)
39.5 Spectrum of Wound Healing
972(3)
39.6 Pressure Injuries
975(3)
Chapter Summary
978(4)
Chapter 40 Acute Skin Disorders
982(29)
40.1
Chapter Overview and Case Studies
983(1)
40.2 Bacterial Skin Infections
984(4)
40.3 Fungal Skin Infections
988(3)
40.4 Dermatitis
991(4)
40.5 Life-threatening Inflammatory Disorders
995(2)
40.6 Stings and Bites
997(2)
40.7 Disorders Caused by Infestations
999(3)
40.8 Disorders Associated with Adolescent/Adult Skin
1002(2)
40.9 Disorders of the Nail
1004(1)
Chapter Summary
1005(6)
Chapter 41 Chronic Skin Disorders
1011(29)
41.1
Chapter Overview and Case Studies
1012(1)
41.2 Viral Skin Infections
1013(4)
41.3 Skin Disorders with a Genetic Basis
1017(6)
41.4 Benign Neoplasms of the Skin
1023(4)
41.5 Skin Cancer
1027(3)
41.6 Changes in Pigmentation of the Skin
1030(2)
41.7 Disorders of the Hair and Scalp
1032(3)
Chapter Summary
1035(5)
Unit XIII: Disorders of Digestion, Metabolism, and Elimination 1040(120)
Chapter 42 Disorders of Upper and Lower Gastrointestinal Systems
1042(28)
42.1
Chapter Overview and Case Studies
1043(2)
42.2 Disorders of the Esophagus
1045(8)
42.3 Disorders of the Stomach
1053(4)
42.4 Disorders of the Small Intestines, Large Intestines, and Rectum
1057(8)
Chapter Summary
1065(5)
Chapter 43 Disorders of the Exocrine Pancreatic and Hepatobiliary Systems
1070(26)
43.1
Chapter Overview and Case Studies
1071(1)
43.2 Disorders of the Liver
1072(11)
43.3 Disorders of the Gallbladder
1083(5)
43.4 Disorders of the Pancreas
1088(4)
Chapter Summary
1092(4)
Chapter 44 Liver Failure
1096(19)
44.1
Chapter Overview and Case Studies
1097(1)
44.2 The Normal Liver
1098(1)
44.3 Clinical Manifestations and Complications of Liver Failure
1099(4)
44.4 Common Causes of Liver Failure
1103(8)
Chapter Summary
1111(4)
Chapter 45 Disorders of Kidney and Urinary Tract Function
1115(20)
45.1
Chapter Overview and Case Studies
1116(2)
45.2 Glomerular Disorders
1118(4)
45.3 Diabetic Nephropathy
1122(1)
45.4 Hypertensive Nephropathy
1123(2)
45.5 Urinary Tract Infections
1125(2)
45.6 Renal Calculi
1127(1)
45.7 Urinary Incontinence
1127(1)
45.8 Benign Tumors and Malignancies of the Kidney and Bladder
1128(2)
Chapter Summary
1130(5)
Chapter 46 Acute Kidney Injury and Chronic Kidney Disease
1135(25)
46.1
Chapter Overview and Case Studies
1136(1)
46.2 Acute Kidney Injury
1137(7)
46.3 Chronic Kidney Disease
1144(11)
Chapter Summary
1155(5)
Unit XIV: Disorders of Sexuality and Reproduction 1160(60)
Chapter 47 Disorders of the Female Reproductive System
1162(30)
47.1
Chapter Overview and Case Studies
1163(1)
47.2 Disorders of the Female Breasts
1164(5)
47.3 Disorders of Menstruation
1169(3)
47.4 Disorders of the Ovaries and Fallopian Tubes
1172(3)
47.5 Disorders of the Uterus
1175(3)
47.6 Disorders of the Cervix, Vagina, and Vulva
1178(3)
47.7 Disorders of the Female Pelvis
1181(1)
47.8 Disorders of Fertility
1182(1)
47.9 Sexual Dysfunction
1183(2)
Chapter Summary
1185(7)
Chapter 48 Disorders of the Male Reproductive System
1192(14)
48.1
Chapter Overview and Case Studies
1193(1)
48.2 Disorders of the Prostate
1194(3)
48.3 Disorders of the Testicles
1197(3)
48.4 Disorders of the Penis
1200(3)
Chapter Summary
1203(3)
Chapter 49 Sexually Transmitted Infections
1206(14)
49.1
Chapter Overview and Case Studies
1207(1)
49.2 Viral STIs
1208(3)
49.3 Bacterial STIs
1211(3)
49.4 Parasitic STIs
1214(2)
Chapter Summary
1216(4)
Unit XV: Trauma and Multisystem Conditions 1220
Chapter 50 Mechanisms of Traumatic Injury
1222(22)
50.1
Chapter Overview and Case Studies
1223(1)
50.2 Modern Trauma Care
1224(2)
50.3 Blunt Trauma
1226(2)
50.4 Penetrating Trauma
1228(3)
50.5 Thermal Injuries
1231(4)
50.6 Chemical Burns
1235(1)
50.7 Electrical Injuries
1236(1)
50.8 Lethal Triad of Trauma
1237(1)
50.9 Trauma Deaths and Trauma Prevention
1238(1)
Chapter Summary
1239(5)
Chapter 51 The Pathophysiology of Primary and Secondary Traumatic Injury
1244(27)
51.1
Chapter Overview and Case Study
1245(3)
51.2 The Primary Survey and Injury
1248(12)
51.3 The Secondary Survey and Injury
1260(6)
Chapter Summary
1266(5)
Chapter 52 Biologic, Chemical, and Radiologic Agents of Disease
1271(20)
52.1
Chapter Overview and Case Studies
1272(2)
52.2 Biologic Agents
1274(7)
52.3 Chemical Agents
1281(4)
52.4 Radiologic and Nuclear Devices
1285(2)
Chapter Summary
1287(4)
Chapter 53 Pathophysiology at the End of Life
1291
53.1
Chapter Overview and Case Studies
1292(3)
53.2 Pain
1295(1)
53.3 Dyspnea
1295(3)
53.4 Cough
1298(1)
53.5 Excessive Secretions
1299(1)
53.6 Nausea and Vomiting
1300(3)
53.7 Anorexia and Cachexia
1303(2)
53.8 Fatigue
1305(1)
53.9 Constipation
1306(1)
53.10 Urinary Incontinence
1307(1)
53.11 Delirium
1308(1)
53.12 Last Expected Changes at the End of Life
1309(2)
53.13 Pediatric Considerations
1311(1)
Chapter Summary
1312
Appendix A: Answers to Review Questions A-0
Glossary G-0
Credits C-0
Index I-0
About our authors The pre-nursing career of Matthew Sorenson, PhD, APN, ANP-C, includes experience as a recovery room orderly, paramedic and childcare worker and an initial collegiate major in history. His nursing career began with a BSN degree from Northern Illinois University (with a minor in history). After graduation, he worked primarily in physical rehabilitation, focusing on neurologic conditions and injury, an area in which he remains active.

He holds an MS in Applied Family and Child Studies (Focus on Abuse and Neglect) and an MS in Nursing (Community Health Focus). His doctorate is from Loyola University Chicago, where he studied stress-related changes in immunologic function in those with multiple sclerosis. Postdoctoral education includes a three-year fellowship with the neurology service at Edward Hines Jr. VA Hospital (focus on multiple sclerosis) and a year-long fellowship in Disability Ethics through the Rehabilitation Institute of Chicago. He is an adult nurse practitioner. His time as a nurse practitioner is spent primarily with street outreach programs targeting the homeless and working poor.

His research focuses on immunologic correlates of fatigue, particularly in those with multiple sclerosis. He is currently funded to investigate viral epigenetics in multiple sclerosis. He teaches physical assessment, pharmacology, medical-surgical nursing and pathophysiology. Academically, Dr. Sorenson teaches at DePaul University with an additional appointment in the School of Medicine (Physical Medicine and Rehabilitation) at Northwestern University. He served as a program director for several years and was recently named Director of the School of Nursing.

Laurie Quinn, PhD, RN, FAAN, FAHA, CDE, is a clinical professor in the Department of Biobehavioral Health Science in the College of Nursing at the University of Illinois at Chicago (UIC). Dr. Quinn earned her PhD from UIC in Nursing Science and has been on the UIC College of Nursing faculty for 20 years. Her primary research focus is the study of metabolic alterations associated with diabetes mellitus, especially their role in the development of cardiovascular disease. Her research has focused on examining the effect of aerobic exercise on the metabolic derangements of both type 1 and type 2 diabetes.

She is currently part of an interdisciplinary team from University of Chicago, Illinois Institute of Technology and UIC that is developing an artificial pancreas. Dr. Quinn is a certified diabetes educator and worked as a clinical nurse specialist at Rush University Medical Center. She has received several awards for teaching excellence and has lectured in graduate and undergraduate physiology, pathophysiology and pharmacology classes. She has published and presented extensively in research and clinical practice venues on diabetes-related topics.

Dr. Quinn is an active member of the American Diabetes Association and American Heart Association. She has been a healthcare coordinator at an American Diabetes Association summer camp for children with diabetes for several years. In this role, she has cared for numerous children with type 1 diabetes and helped to educate clinical staff and students from various healthcare specialties on the treatment of type 1 diabetes.

Diane Klein, PhD, RN, earned a BSN degree from Loyola University Chicago and then worked as a nurse in the trauma unit and medical units at Cook County Hospital. During her clinical practice, she became interested in research, which led her to earn a PhD in physiology from the University of Illinois at the Medical Center Campus in Chicago. Her research interests as a faculty member at Loyola University Chicago have included the role of cyclic nucleotides in altered lung metabolism during septic shock, and the use of nebulized morphine in the treatment of dyspnea.

Dr. Klein was an associate professor in the School of Nursing at Loyola University Chicago, where she taught undergraduate and graduate pathophysiology courses for over 30 years. She believed that nursing students require a strong foundation in pathophysiology because it is the basis for their understanding of pharmacology and the rationale for clinical assessments and interventions. In addition to pathophysiology courses, Dr. Klein taught adult health clinical courses, pharmacology, advanced physiology for clinical practice, and stress in health and illness.

In addition to teaching, Dr. Klein presented topics related to pathophysiology at local and national meetings of both nursing and basic science organizations. Selected topics presented include resources for teaching genetics and genomics, problems of mechanically ventilated patients, biotrauma, effects of endotoxin and cyclic nucleotides on lung glucose oxidation, and oxidative stress in critical illness and therapeutic strategies.